Drug Discovery Webinars
-
Which Studies Are Required As Part Of An IND Program?
5/16/2023
IND-enabling studies are the foundation of the drug development process, helping researchers predict safety concerns, estimate efficacious starting doses for clinical trials, and meet development timelines and milestones.
-
Applying To Conduct A Clinical Trial
5/16/2023
Creating realistic expectations for regulatory considerations, necessary materials for IND submission, and approval timelines early in development is essential for reaching IND program milestones on-time and within budget.
-
Current Trends In Toxicology
4/18/2023
As developers balance safety concerns with pressure for accelerated development, hear experts discuss the innovations in culture systems and characterization that are enabling a safe, efficient pathway to successful IND.
-
Microfluidic 3D Liver-On-Chip Model: Application In Genetic Toxicology
4/13/2023
Developing a toxicology battery with specific assays is crucial to mitigate risk. Examine this study's results and how the findings could help increase accuracy of assays in human models.
-
Animal Models In Ocular Gene Therapy
4/13/2023
Various animal models — including non-human primates, rabbits, minipigs, and canines — present benefits and limitations for preclinical studies. Explore the insights to optimize the path to clinical trials.
-
Successful Clinical Manufacturing Of Cell And Gene Therapies
3/27/2023
While biotech companies face pressure to rush to trials, development still requires a significant amount of work. This panel explores the pitfalls for developers and indicators of GMP readiness.
-
Navigating The Small Molecule CMC Pathway
1/19/2023
Advancing a small molecule candidate from discovery to clinic is a complicated journey. Learn more about the factors that can accelerate timelines and help improve downstream clinical outcomes.
-
Spotlight On Discovery Biology With Dr. Jayashree Aiyar
11/28/2022
Dr. Jayashree Aiyar, VP and Head of Discovery Biology, highlights key research areas for global pharma and biotechs, including exciting projects spanning PROTACs, cell and gene therapy, omics, and more.
-
Improving The Enrichment Of Mononuclear Cells For CAR T Cell Therapies: The Importance Of Platelet Depletion
7/26/2022
Explore why, how, and when you should carry out platelet depletion to achieve successful T cell enrichment.
-
Biopharmaceutics In Early Drug Development - Overcoming Challenges For Small Molecules
7/19/2022
Chris Roe, Principal Research Fellow at Quotient Sciences, discusses effective strategies to overcome biopharmaceutic challenges for small molecules in today’s drug development pipeline.